Latest From AltheaDx Inc.
The unexpected firing of Arcturus CEO Joseph Payne kicked off a bitter public battle for control of the RNA therapeutics firm after a reverse merger with Alcobra in November. The dispute now settled, the new board has reinstated Payne at Arcturus' helm.
Permira has signed a deal to acquire a majority stake in orthopedics group Corin from a group of investors for an undisclosed price.
Epigenomics, RainDance, and Brightree name new leadership, and more personnel news from around the industry.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.
Drug Discovery Tools
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Laboratory Testing Services
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- AltheaDx Inc.
- Senior Management
Andrew Jackson, CFO
Jorge Garces, PhD, Pres. & COO
Joel Centeno, SVP, Regulatory, Quality & Clinical
Lukowiak A Andrew, PhD, SVP, Ops, Head of Scientific Affairs
- Contact Info
Phone: (855) 697-4943
10578 Science Center Dr.
San Diego, CA 92121
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.